Lamicone NS Tablet contains a combination of Lamivudine 150mg, Stavudine 40mg, and Nevirapine 200mg, a potent antiretroviral therapy (ART) formulation indicated for the management of HIV infection. It helps in suppressing viral replication, controlling viral load, and supporting immune system health.
This combination works through multiple mechanisms: Lamivudine and Stavudine inhibit reverse transcriptase, while Nevirapine blocks viral replication at a different site. Together, they provide comprehensive viral suppression and improve long-term immune function in HIV-positive patients.
For distributors and healthcare suppliers, Lamicone NS Tablet is a high-demand ART product, widely prescribed by infectious disease specialists, HIV clinics, and hospitals. The growing need for effective HIV management ensures consistent market demand across urban and rural healthcare networks.
Adding Lamicone NS Tablet to your antiretroviral and viral suppression segment provides strong opportunities in pharmacies, HIV care centers, hospital supply chains, export markets, and third-party manufacturing. Its clinically proven efficacy, patient adherence profile, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.